Clinical Trials Directory

Trials / Completed

CompletedNCT01282346

SOLX Gold Shunt for Refractory Glaucoma

Clinical Evaluation of the SOLX Gold Shunt for the Reduction of Intraocular Pressure (IOP) in Refractory Glaucoma

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
116 (actual)
Sponsor
SOLX, Inc. · Industry
Sex
All
Age
21 Years
Healthy volunteers
Not accepted

Summary

To establish the clinical performance of the SOLX Gold Shunt for its ability to reduce intraocular pressure (IOP) in eyes with refractory glaucoma where medical and conventional surgical treatments have failed.

Conditions

Interventions

TypeNameDescription
DEVICESOLX Gold ShuntSingle use implant

Timeline

Start date
2011-01-01
Primary completion
2015-12-01
Completion
2015-12-01
First posted
2011-01-25
Last updated
2017-02-23

Locations

17 sites across 5 countries: United States, Brazil, Canada, Israel, Venezuela

Source: ClinicalTrials.gov record NCT01282346. Inclusion in this directory is not an endorsement.

SOLX Gold Shunt for Refractory Glaucoma (NCT01282346) · Clinical Trials Directory